Literature DB >> 11582791

Leczyme.

K Nitta1.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11582791     DOI: 10.1016/s0076-6879(01)41164-5

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  4 in total

1.  Sialyl-glycoconjugates in cholesterol-rich microdomains of P388 cells are the triggers for apoptosis induced by Rana catesbeiana oocyte ribonuclease.

Authors:  Y Ogawa; S Sugawara; T Tatsuta; M Hosono; K Nitta; Y Fujii; H Kobayashi; T Fujimura; H Taka; Y Koide; I Hasan; R Matsumoto; H Yasumitsu; R A Kanaly; S M A Kawsar; Y Ozeki
Journal:  Glycoconj J       Date:  2013-11-24       Impact factor: 2.916

Review 2.  Leczyme: a new candidate drug for cancer therapy.

Authors:  Takeo Tatsuta; Shigeki Sugawara; Kohta Takahashi; Yukiko Ogawa; Masahiro Hosono; Kazuo Nitta
Journal:  Biomed Res Int       Date:  2014-04-23       Impact factor: 3.411

Review 3.  Cancer-selective induction of apoptosis by leczyme.

Authors:  Takeo Tatsuta; Shigeki Sugawara; Kohta Takahashi; Yukiko Ogawa; Masahiro Hosono; Kazuo Nitta
Journal:  Front Oncol       Date:  2014-06-04       Impact factor: 6.244

4.  Sialic acid-binding lectin (leczyme) induces apoptosis to malignant mesothelioma and exerts synergistic antitumor effects with TRAIL.

Authors:  Takeo Tatsuta; Masahiro Hosono; Kohta Takahashi; Takashi Omoto; Yukiko Kariya; Shigeki Sugawara; Senitiroh Hakomori; Kazuo Nitta
Journal:  Int J Oncol       Date:  2013-11-28       Impact factor: 5.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.